CAMBRIDGE, Mass.--(BUSINESS WIRE)--Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the company’s launch and $100 million in initial ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the presentation of preclinical data that demonstrate ...
April 15 (UPI) --A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from the hospital in February, according to biotech firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback